EDIT Editas Medicine Inc

USD 1.34 -0.01 ( -0.37)%
Icon

Editas Medicine Inc (EDIT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 1.34

-0.01 (-0.37)%

USD 0.12B

2.47M

USD 6.67(+397.84%)

USD 16.00 (+1094.03%)

Icon

EDIT

Editas Medicine Inc (USD)
COMMON STOCK | NSD
USD 1.34
-0.01 ( -0.37)%

Editas Medicine Inc (EDIT) Stock Forecast

Show ratings and price targets of :
USD 6.67
(+397.84%)

Based on the Editas Medicine Inc stock forecast from 11 analysts, the average analyst target price for Editas Medicine Inc is USD 6.67 over the next 12 months. Editas Medicine Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Editas Medicine Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Editas Medicine Inc’s stock price was USD 1.34. Editas Medicine Inc’s stock price has changed by -29.10% over the past week, -45.97% over the past month and -87.83% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...